Effects of hydroxyethylstarch and gelatin on renal function in severe sepsis: a multicentre randomised study
- PMID:11289347
- DOI: 10.1016/S0140-6736(00)04211-2
Effects of hydroxyethylstarch and gelatin on renal function in severe sepsis: a multicentre randomised study
Abstract
Background: Hydroxyethylstarch used for volume restoration in brain-dead kidney donors has been associated with impaired kidney function in the transplant recipients. We undertook a multicentre randomised study to assess the frequency of acute renal failure (ARF) in patients with severe sepsis or septic shock treated with hydroxyethylstarch or gelatin.
Methods: Adults with severe sepsis or septic shock were enrolled prospectively in three intensive-care units in France. They were randomly assigned 6% hydroxyethylstarch (200 kDa, 0.60-0.66 substitution) or 3% fluid-modified gelatin. The primary endpoint was ARF (a two-fold increase in serum creatinine from baseline or need for renal replacement therapy). Analyses were by intention to treat.
Findings: 129 patients were enrolled over 18 months. Severity of illness and serum creatinine (median 143 [IQR 88-203] vs 114 [91-175] micromol/L) were similar at baseline in the hydroxyethylstarch and gelatin groups. The frequencies of ARF (27/65 [42%] vs 15/64 [23%], p=0.028) and oliguria (35/62 [56%] vs 23/63 [37%], p=0.025) and the peak serum creatinine concentration (225 [130-339] vs 169 [106-273] micromol/L, p=0.04) were significantly higher in the hydroxyethylstarch group than in the gelatin group. In a multivariate analysis, risk factors for acute renal failure included mechanical ventilation (odds ratio 4.02 [95% CI 1.37-11.8], p=0.013) and use of hydroxyethylstarch (2.57 [1.13-5.83], p=0.026).
Interpretations: The use of this preparation of hydroxyethylstarch as a plasma-volume expander is an independent risk factor for ARF in patients with severe sepsis or septic shock.
Comment in
- Hydroxyethylstarch as a risk factor for acute renal failure in severe sepsis.Boldt J.Boldt J.Lancet. 2001 Aug 18;358(9281):581-3. doi: 10.1016/S0140-6736(01)05720-8.Lancet. 2001.PMID:11526920No abstract available.
- Hydroxyethylstarch as a risk factor for acute renal failure in severe sepsis.Gosling P, Rittoo D, Manji M, Mahmood A, Vohra R.Gosling P, et al.Lancet. 2001 Aug 18;358(9281):581; author reply 582. doi: 10.1016/S0140-6736(01)05718-X.Lancet. 2001.PMID:11526921No abstract available.
- Hydroxyethylstarch as a risk factor for acute renal failure in severe sepsis.Godet G.Godet G.Lancet. 2001 Aug 18;358(9281):581; author reply 582. doi: 10.1016/S0140-6736(01)05719-1.Lancet. 2001.PMID:11526922No abstract available.
Similar articles
- Hydroxyethylstarch as a risk factor for acute renal failure in severe sepsis.Boldt J.Boldt J.Lancet. 2001 Aug 18;358(9281):581-3. doi: 10.1016/S0140-6736(01)05720-8.Lancet. 2001.PMID:11526920No abstract available.
- Hydroxyethylstarch as a risk factor for acute renal failure in severe sepsis.Godet G.Godet G.Lancet. 2001 Aug 18;358(9281):581; author reply 582. doi: 10.1016/S0140-6736(01)05719-1.Lancet. 2001.PMID:11526922No abstract available.
- Hydroxyethylstarch as a risk factor for acute renal failure in severe sepsis.Gosling P, Rittoo D, Manji M, Mahmood A, Vohra R.Gosling P, et al.Lancet. 2001 Aug 18;358(9281):581; author reply 582. doi: 10.1016/S0140-6736(01)05718-X.Lancet. 2001.PMID:11526921No abstract available.
- Hydroxyethylstarch as a risk factor for acute renal failure: is a change of clinical practice indicated?Boldt J.Boldt J.Drug Saf. 2002;25(12):837-46. doi: 10.2165/00002018-200225120-00002.Drug Saf. 2002.PMID:12241125Review.
- Renal impact of fluid management with colloids: a comparative review.Davidson IJ.Davidson IJ.Eur J Anaesthesiol. 2006 Sep;23(9):721-38. doi: 10.1017/S0265021506000639. Epub 2006 May 24.Eur J Anaesthesiol. 2006.PMID:16723059Review.
Cited by
- Permanent renal failure induced by pentastarch.Jamal R, Ghannoum M, Naud JF, Turgeon PP, Leblanc M.Jamal R, et al.NDT Plus. 2008 Oct;1(5):322-5. doi: 10.1093/ndtplus/sfn075. Epub 2008 Jun 23.NDT Plus. 2008.PMID:25983924Free PMC article.
- Resuscitation with low volume hydroxyethylstarch 130 kDa/0.4 is not associated with acute kidney injury.Boussekey N, Darmon R, Langlois J, Alfandari S, Devos P, Meybeck A, Chiche A, Georges H, Leroy O.Boussekey N, et al.Crit Care. 2010;14(2):R40. doi: 10.1186/cc8920. Epub 2010 Mar 18.Crit Care. 2010.PMID:20298543Free PMC article.
- Year in review in Intensive Care Medicine, 2006. II. Infections and sepsis, haemodynamics, elderly, invasive and noninvasive mechanical ventilation, weaning, ARDS.Andrews P, Azoulay E, Antonelli M, Brochard L, Brun-Buisson C, De Backer D, Dobb G, Fagon JY, Gerlach H, Groeneveld J, Macrae D, Mancebo J, Metnitz P, Nava S, Pugin J, Pinsky M, Radermacher P, Richard C.Andrews P, et al.Intensive Care Med. 2007 Feb;33(2):214-29. doi: 10.1007/s00134-006-0512-z. Epub 2007 Jan 13.Intensive Care Med. 2007.PMID:17221187Free PMC article.Review.No abstract available.
- Choosing a volume expander in critical care medicine.Kissoon N, Bohn D.Kissoon N, et al.Indian J Pediatr. 2003 Dec;70(12):969-73. doi: 10.1007/BF02723823.Indian J Pediatr. 2003.PMID:14719786Review.
- [Limited applications for hydroxyethyl starch : background and alternative concepts].Rehm M.Rehm M.Anaesthesist. 2013 Aug;62(8):644-55. doi: 10.1007/s00101-013-2220-8.Anaesthesist. 2013.PMID:23925465Review.German.
Publication types
MeSH terms
Substances
Related information
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical